- Lupin Strikes $90m Settlement With Astellas On Myrbetriq
- Organon And Henlius Settle US Perjeta Litigation
- Fresenius Kabi And Phlow Partner On End-To-End US Epinephrine Supply Chain
- CVS Health beats the Street on both earnings, revenue in Q4
- CVS Health beats the Street on both earnings, revenue in Q4
- Care navigation startup Garner Health scores $118M series D at $1.35B valuation
- Care navigation startup Garner Health scores $118M series D at $1.35B valuation
- CMS plans to roll back limits on nonstandard ACA plan options
- CMS plans to roll back limits on nonstandard ACA plan options
- Bio-Thera Partners With Avalon Pharma For Keytruda Biosimilar In Middle East
- Lupin Strikes $90m Settlement With Astellas On Myrbetriq
- Organon And Henlius Settle US Perjeta Litigation
- Fresenius Kabi And Phlow Partner On End-To-End US Epinephrine Supply Chain
- CVS Health beats the Street on both earnings, revenue in Q4
- Care navigation startup Garner Health scores $118M series D at $1.35B valuation
- CMS plans to roll back limits on nonstandard ACA plan options
- Bio-Thera Partners With Avalon Pharma For Keytruda Biosimilar In Middle East
- Mental health startups chosen for One Mind Accelerator
- Breckenridge Expands Injectables Portfolio Through Medichem Collaboration
- Doximity CEO bullish on winning the AI market in 2026 as it rolls out physician-led AI review
Tag: Gene Therapy
| # | Post Title | Date | User |
| Media Lying About Peter Marks Departure From FDA | 11 months ago | 10x25mm | |
| Michigan Association of Health Plans Asks DIFS To Clarify Gene And Cell Therapy Coverage Requirements | 2 years ago | 10x25mm | |
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
Friends of MHF
Kirsten DeVries
Tom & Karen Nunheimer
Steve Ahonen
Ron & Faith Bosserman
Marlin & Kathy Klumpp
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
